These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 18774757)

  • 21. Therapeutic use of the LNG IUS, and counseling.
    Pakarinen P; Toivonen J; Luukkainen T
    Semin Reprod Med; 2001 Dec; 19(4):365-72. PubMed ID: 11727178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
    Yoo HJ; Lee MA; Ko YB; Yang JB; Kang BH; Lee KH
    Arch Gynecol Obstet; 2012 Jan; 285(1):161-6. PubMed ID: 21671063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirena intra-uterine system: does it improve long term symptoms in women with chronic pelvic pain and/or endometriosis after laparoscopy? A multicentre randomized controlled trial.
    Alhamdan D; Bignardi T; Hardas G; Merkur H; Condous G
    Rev Recent Clin Trials; 2010 Sep; 5(3):143-6. PubMed ID: 20482495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
    Lan S; Ling L; Jianhong Z; Xijing J; Lihui W
    J Int Med Res; 2013 Jun; 41(3):548-58. PubMed ID: 23660087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
    Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicated intrauterine systems for treatment of endometriosis-associated pain.
    Muzii L
    J Minim Invasive Gynecol; 2006; 13(6):535-8. PubMed ID: 17097576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-contraceptive health benefits of intrauterine hormonal systems.
    Fraser IS
    Contraception; 2010 Nov; 82(5):396-403. PubMed ID: 20933112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Abou-Setta AM; Houston B; Al-Inany HG; Farquhar C
    Cochrane Database Syst Rev; 2013 Jan; (1):CD005072. PubMed ID: 23440798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
    Heikinheimo O; Lehtovirta P; Suni J; Paavonen J
    Hum Reprod; 2006 Nov; 21(11):2857-61. PubMed ID: 16880227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
    Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
    Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review.
    Ramhendar T; Byrne P
    Contraception; 2012 Sep; 86(3):288-9. PubMed ID: 22305914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire.
    Radesic B; Sharma A
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
    He SM; Zhang YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the levonorgestrel intrauterine system in adolescents with endometriosis.
    Yoost J; LaJoie AS; Hertweck P; Loveless M
    J Pediatr Adolesc Gynecol; 2013 Apr; 26(2):120-4. PubMed ID: 23518190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system.
    Gemzell-Danielsson K; Inki P; Heikinheimo O
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1177-88. PubMed ID: 21854367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The levonorgestrel intrauterine system in nulliparous women.
    Prager S; Darney PD
    Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
    Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
    Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.